A medical device and methods for altering lung volume are disclosed. The medical device includes a coil formed of a biodegradable material including a first bioabsorbable material that is configured to deactivate a portion of a lung as the coil degrades. The method includes positioning a first coil adjacent a first target within a patient and permitting the first coil to degenerate such that a first bioabsorbable material deactivates a first portion of a lung. The first coil is formed of a biodegradable material and includes the first bioabsorbable material.

A lung volume reduction system is disclosed comprising an implantable device adapted to be delivered to a lung airway of a patient in a delivery configuration and to change to a deployed configuration to bend the lung airway. The invention also discloses a method of bending a lung airway of a patient comprising inserting a device into the airway in a delivery configuration and bending the device into a deployed configuration, thereby bending the airway.

A stent Includes a stent body formed by a strut. The stent body is cylindrically-shaped and extends in an axial direction. The stent body includes a plurality of helical portions and an annular portion. The strut is helically-shaped along the axial direction to form the plurality of helical portions and the strut is annularly-shaped in the circumferential direction to form the annular portion. Each of the plurality of helical portions has a distal end point and a proximal end point. The plurality of helical portions include a first helical portion and a second helical portion adjacent to the first helical portion in the axial direction. The annular portion is disposed between the first and second helical portions in the axial direction. At least one of the distal and proximal end points of the plurality of helical portions is directly connected to the annular portion.

A stent includes a strut formed into a cylindrical shape and extending in an axial direction. The strut includes outer peripheral portions extending around the axial and circumferential directions of the cylindrical shape. The outer peripheral portions are spaced apart from one another with gaps formed between adjacent outer peripheral portions. The strut includes a connection portion connecting the outer peripheral portions to each other in one of the gaps formed by the adjacent outer peripheral portions. The outer peripheral portions and the connection portion of the strut are integrally formed of a biodegradable polymer A portion of the strut includes a fragile portion which is snore fragile than other portions of the strut.

A valve comprising: (a) a rod, (b) a plurality of struts in communication with the rod and extending generally radially outward away from the rod in a deployed state, the plurality of struts including at least: (i) a plurality of first struts that extend radially outward from the rod a first distance, and (ii) a plurality of second struts that extend radially outward a second distance from the rod, wherein the second distance is less than the first distance; and (c) one or more membranes that are in communication with the first struts, the second struts, or both.

This disclosure concerns systems and methods for tissue volume reduction and control of the flow of substances through the body. Systems according to the various embodiments of the disclosure include check valves formed from wire coils which are deployable through a tubular lumen, such as the working channel of an endoscope, or a catheter.

An endoprosthesis configured to shift between a collapsed configuration and an expanded configuration may include a tubular scaffold formed from a single filament knitted about a central longitudinal axis and defining a length from a proximal end to a distal end, the tubular scaffold including a plurality of rows of loops and a plurality of rows of rungs arranged around the central longitudinal axis in an alternating fashion; and a polymeric covering extending along the tubular scaffold. Each row of loops and each row of rungs extends longitudinally along the tubular scaffold between the proximal end and the distal end. The tubular scaffold includes a first cutout region extending along a majority of the length of the tubular scaffold and a second cutout region extending along a majority of the length of the tubular scaffold. The polymeric covering is uninterrupted along the first cutout region and the second cutout region.

The present invention relates to a stent delivery device having: a first support rod into which a first movable body is inserted; a fixed magnet; and a second support rod into which a second movable body is inserted, wherein a first driving magnet included in the first movable body and a second driving magnet included in the second movable body rotate relative to each other by means of the control of an external magnetic field at a predetermined angle around an axis in a first direction with respect to the fixed magnet, thereby separating a first coupling piece and a second coupling piece from a first coupling groove and a second coupling groove and enabling a stent to unfold.

Aspects of the disclosure relate methods and synthetic scaffolds for regenerating gastrointestinal tissue (e.g., esophageal tissue).

An implant (500) comprises an elastic deformation portion (51) and a connection portion (52) connected with the proximal end (511) of the elastic deformation portion (51), wherein the elastic deformation portion (51) is covered by an elastic outer layer (55); the proximal end of the connection portion (52) is surrounded by a tightening ring (58); and the proximal end of the elastic outer layer (55) is covered by the tightening ring (58). Since the proximal end of the elastic outer layer (55) of the implant (500) is surrounded by a tightening ring (58), the elastic outer layer (55) is closely attached on the connecting portion (52) of the implant (500), such that the elastic outer layer (55) can be prevented from being rolled over from the surface of the implant (500) when the implant (500) is implanted, thereby improving safety of lung volume reduction surgery.